Literature DB >> 25209046

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

Qiupeng Zheng1, Xiaohong Cai2, Meng How Tan3, Steven Schaffert2, Christopher P Arnold2, Xue Gong2, Chang-Zheng Chen4, Shenglin Huang5.   

Abstract

The prokaryotic type II CRISPR/Cas9 system has been adapted to perform targeted genome editing in cells and model organisms. Here, we describe targeted gene deletion and replacement in human cells via the CRISPR/Cas9 system using two guide RNAs. The system effectively generated targeted deletions of varied length, regardless of the transcriptional status of the target gene. It is notable that targeted gene deletions generated via CRISPR/Cas9 and two guide RNAs resulted in the formation of correct junctions at high efficiency. Moreover, in the presence of a homology repair donor, the CRISPR/Cas9 system could guide precise gene replacement. Our results illustrate that the CRISPR/Cas9 system can be used to precisely and effectively generate targeted deletions or gene replacement in human cells, which will facilitate characterization of functional domains in protein-coding genes as well as noncoding regulatory sequences in animal genomes.

Entities:  

Keywords:  CRISPR/Cas9; Genome editing; deletion; replacement

Mesh:

Year:  2014        PMID: 25209046     DOI: 10.2144/000114196

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  64 in total

1.  Knockout of cGAS and STING Rescues Virus Infection of Plasmid DNA-Transfected Cells.

Authors:  Martijn A Langereis; Huib H Rabouw; Melle Holwerda; Linda J Visser; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Omics Assisted N-terminal Proteoform and Protein Expression Profiling On Methionine Aminopeptidase 1 (MetAP1) Deletion.

Authors:  Veronique Jonckheere; Daria Fijałkowska; Petra Van Damme
Journal:  Mol Cell Proteomics       Date:  2018-01-09       Impact factor: 5.911

Review 3.  Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.

Authors:  Hua Shen; Cliona M McHale; Martyn T Smith; Luoping Zhang
Journal:  Mutat Res Rev Mutat Res       Date:  2015-01-25       Impact factor: 5.657

4.  In Vivo Silencing/Overexpression of lncRNAs by CRISPR/Cas System.

Authors:  Marianna Vitiello; Laura Poliseno; Pier Paolo Pandolfi
Journal:  Methods Mol Biol       Date:  2021

5.  CRISPR/Cas Technologies Applied to Pseudogenes.

Authors:  Marianna Vitiello; Laura Poliseno
Journal:  Methods Mol Biol       Date:  2021

6.  Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.

Authors:  Shiyou Zhu; Wei Li; Jingze Liu; Chen-Hao Chen; Qi Liao; Ping Xu; Han Xu; Tengfei Xiao; Zhongzheng Cao; Jingyu Peng; Pengfei Yuan; Myles Brown; Xiaole Shirley Liu; Wensheng Wei
Journal:  Nat Biotechnol       Date:  2016-10-31       Impact factor: 54.908

7.  CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10.

Authors:  Guo-Xiang Ruan; Elizabeth Barry; Dan Yu; Michael Lukason; Seng H Cheng; Abraham Scaria
Journal:  Mol Ther       Date:  2017-01-18       Impact factor: 11.454

Review 8.  Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling.

Authors:  Thomas Ratajczak; Carmel Cluning; Bryan K Ward
Journal:  Clin Biochem Rev       Date:  2015-05

9.  The ATF3 Transcription Factor Is a Short-Lived Substrate of the Arg/N-Degron Pathway.

Authors:  Tri T M Vu; Alexander Varshavsky
Journal:  Biochemistry       Date:  2020-07-21       Impact factor: 3.162

10.  A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assembly.

Authors:  Nathalie Eisenhardt; Viduth K Chaugule; Stefanie Koidl; Mathias Droescher; Esen Dogan; Jan Rettich; Päivi Sutinen; Susumu Y Imanishi; Kay Hofmann; Jorma J Palvimo; Andrea Pichler
Journal:  Nat Struct Mol Biol       Date:  2015-11-02       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.